These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 15056058

  • 1. Radiation-guided drug delivery systems.
    Stacy DR, Lu B, Hallahan DE.
    Expert Rev Anticancer Ther; 2004 Apr; 4(2):283-8. PubMed ID: 15056058
    [Abstract] [Full Text] [Related]

  • 2. Radiation sensitizers: a selective review of molecules targeting DNA and non-DNA targets.
    Kvols LK.
    J Nucl Med; 2005 Jan; 46 Suppl 1():187S-90S. PubMed ID: 15653668
    [Abstract] [Full Text] [Related]

  • 3. Radiation-mediated control of drug delivery.
    Hallahan DE, Qu S, Geng L, Cmelak A, Chakravarthy A, Martin W, Scarfone C, Giorgio T.
    Am J Clin Oncol; 2001 Oct; 24(5):473-80. PubMed ID: 11586099
    [Abstract] [Full Text] [Related]

  • 4. Trends in immunoconjugate and ligand-receptor based targeting development for cancer therapy.
    Brumlik MJ, Daniel BJ, Waehler R, Curiel DT, Giles FJ, Curiel TJ.
    Expert Opin Drug Deliv; 2008 Jan; 5(1):87-103. PubMed ID: 18095930
    [Abstract] [Full Text] [Related]

  • 5. Nanoparticle and targeted systems for cancer therapy.
    Brannon-Peppas L, Blanchette JO.
    Adv Drug Deliv Rev; 2004 Sep 22; 56(11):1649-59. PubMed ID: 15350294
    [Abstract] [Full Text] [Related]

  • 6. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.
    Maeda H, Bharate GY, Daruwalla J.
    Eur J Pharm Biopharm; 2009 Mar 22; 71(3):409-19. PubMed ID: 19070661
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Nanoparticles for delivery of chemotherapeutic agents to tumors.
    Vijayaraghavalu S, Raghavan D, Labhasetwar V.
    Curr Opin Investig Drugs; 2007 Jun 22; 8(6):477-84. PubMed ID: 17621878
    [Abstract] [Full Text] [Related]

  • 12. Nanoparticle technologies for cancer therapy.
    Alexis F, Pridgen EM, Langer R, Farokhzad OC.
    Handb Exp Pharmacol; 2010 Jun 22; (197):55-86. PubMed ID: 20217526
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Radiation-guided drug delivery to tumor blood vessels results in improved tumor growth delay.
    Geng L, Osusky K, Konjeti S, Fu A, Hallahan D.
    J Control Release; 2004 Oct 19; 99(3):369-81. PubMed ID: 15451595
    [Abstract] [Full Text] [Related]

  • 15. New concepts for phase I trials: evaluating new drugs combined with radiation therapy.
    Deutsch E, Soria JC, Armand JP.
    Nat Clin Pract Oncol; 2005 Sep 19; 2(9):456-65. PubMed ID: 16264990
    [Abstract] [Full Text] [Related]

  • 16. Selective or targeted gene/drug delivery for liver tumors: advantages and current status of local delivery.
    Kim YI, Chung JW.
    Expert Rev Gastroenterol Hepatol; 2008 Dec 19; 2(6):791-802. PubMed ID: 19090739
    [Abstract] [Full Text] [Related]

  • 17. [Application of monoclonal antibody for drug delivery system--missile therapy for cancer].
    Yamaguchi T, Takahashi T, Kitamura K, Otsuji E, Sakakura C, Okamoto K, Tsuruta H, Ichikawa D, Matsumura H, Yamamoto K, Nishida T, Kimura A.
    Nihon Rinsho; 1998 Mar 19; 56(3):638-43. PubMed ID: 9549349
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.